Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. (RXDX) Stock Overview
Explore Prometheus Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
9.6B
P/E Ratio
-57.28
EPS (TTM)
$-3.54
ROE
-0.31%
RXDX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Prometheus Biosciences, Inc. (RXDX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $356.60.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -57.28 and a market capitalization of 9.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.